Literature DB >> 31736048

Immune evasion by adenoviruses: a window into host-virus adaptation.

Edson R A Oliveira1, Marlene Bouvier1.   

Abstract

Human adenoviruses (HAdVs) are widespread pathogens that cause a number of partially overlapping, species-specific infections associated with respiratory, urinary, gastrointestinal, and ocular diseases. The early 3 (E3) region of adenoviruses is highly divergent between different species, and it encodes a multitude of proteins with immunomodulatory functions. The study of genetic diversity in the E3 region offers a unique opportunity to gain insight into how the various HAdVs have evolutionarily adapted in response to the selection pressures exerted by host immune defenses. The objective of this review was to discuss subversion of host antiviral immune responses by HAdVs, with a focus on suppression of MHC class I antigen presentation, as a window into host-HAdV adaptation.
© 2019 Federation of European Biochemical Societies.

Entities:  

Keywords:  E1A region; E3 region; E3-19K protein; MHC class I antigen presentation; adenovirus; host immunity; viral immune evasion

Mesh:

Substances:

Year:  2019        PMID: 31736048      PMCID: PMC8034605          DOI: 10.1002/1873-3468.13682

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  71 in total

1.  Adenovirus E3/19K promotes evasion of NK cell recognition by intracellular sequestration of the NKG2D ligands major histocompatibility complex class I chain-related proteins A and B.

Authors:  Brian P McSharry; Hans-Gerhard Burgert; Douglas P Owen; Richard J Stanton; Virginie Prod'homme; Martina Sester; Katja Koebernick; Veronika Groh; Thomas Spies; Steven Cox; Ann-Margaret Little; Eddie C Y Wang; Peter Tomasec; Gavin W G Wilkinson
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

2.  Characterization of E3/49K, a novel, highly glycosylated E3 protein of the epidemic keratoconjunctivitis-causing adenovirus type 19a.

Authors:  Mark Windheim; Hans-Gerhard Burgert
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

3.  The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis.

Authors:  J Shisler; C Yang; B Walter; C F Ware; L R Gooding
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

4.  ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor.

Authors:  D Cosman; J Müllberg; C L Sutherland; W Chin; R Armitage; W Fanslow; M Kubin; N J Chalupny
Journal:  Immunity       Date:  2001-02       Impact factor: 31.745

5.  Differential association between two human MHC class I antigens and an adenoviral glycoprotein.

Authors:  L Severinsson; I Martens; P A Peterson
Journal:  J Immunol       Date:  1986-08-01       Impact factor: 5.422

6.  Adenovirus type 12 early region 1A proteins repress class I HLA expression in transformed human cells.

Authors:  R Vasavada; K B Eager; G Barbanti-Brodano; A Caputo; R P Ricciardi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

7.  Human adenovirus-specific CD8+ T-cell responses are not inhibited by E3-19K in the presence of gamma interferon.

Authors:  P Flomenberg; V Piaskowski; R L Truitt; J T Casper
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

8.  Conserved amino acids within the adenovirus 2 E3/19K protein differentially affect downregulation of MHC class I and MICA/B proteins.

Authors:  Martina Sester; Katja Koebernick; Douglas Owen; Minghui Ao; Yana Bromberg; Ed May; Emily Stock; Lawrence Andrews; Veronika Groh; Thomas Spies; Alexander Steinle; Beatrice Menz; Hans-Gerhard Burgert
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

9.  The human herpesvirus-7 (HHV-7) U21 immunoevasin subverts NK-mediated cytoxicity through modulation of MICA and MICB.

Authors:  Christine L Schneider; Amy W Hudson
Journal:  PLoS Pathog       Date:  2011-11-10       Impact factor: 6.823

10.  No evidence of a death-like function for species B1 human adenovirus type 3 E3-9K during A549 cell line infection.

Authors:  Kathryn M Frietze; Samuel K Campos; Adriana E Kajon
Journal:  BMC Res Notes       Date:  2012-08-11
View more
  5 in total

1.  The FDA-Approved Drug Nelfinavir Inhibits Lytic Cell-Free but Not Cell-Associated Nonlytic Transmission of Human Adenovirus.

Authors:  Fanny Georgi; Vardan Andriasyan; Robert Witte; Luca Murer; Silvio Hemmi; Lisa Yu; Melanie Grove; Nicole Meili; Fabien Kuttler; Artur Yakimovich; Gerardo Turcatti; Urs F Greber
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

2.  Directed attenuation to enhance vaccine immunity.

Authors:  Rustom Antia; Hasan Ahmed; James J Bull
Journal:  PLoS Comput Biol       Date:  2021-02-01       Impact factor: 4.475

3.  The Oncolytic Adenovirus XVir-N-31, in Combination with the Blockade of the PD-1/PD-L1 Axis, Conveys Abscopal Effects in a Humanized Glioblastoma Mouse Model.

Authors:  Moritz Klawitter; Ali El-Ayoubi; Jasmin Buch; Jakob Rüttinger; Maximilian Ehrenfeld; Eva Lichtenegger; Marcel A Krüger; Klaus Mantwill; Florestan J Koll; Markus C Kowarik; Per Sonne Holm; Ulrike Naumann
Journal:  Int J Mol Sci       Date:  2022-09-01       Impact factor: 6.208

Review 4.  Understanding Post Entry Sorting of Adenovirus Capsids; A Chance to Change Vaccine Vector Properties.

Authors:  Coralie F Daussy; Noémie Pied; Harald Wodrich
Journal:  Viruses       Date:  2021-06-24       Impact factor: 5.048

5.  Intracellular Sequestration of the NKG2D Ligand MIC B by Species F Adenovirus.

Authors:  Edson R A Oliveira; Lenong Li; Marlene Bouvier
Journal:  Viruses       Date:  2021-07-01       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.